Expansion Opportunity Vivacy is expanding across Europe and beyond with distributors in 70+ countries and new strategic partnerships forming, presenting a sales opportunity to align with regional distributors or to pursue co-marketing and bundled offerings with complementary brands.

Regenerative Focus Strength in IPN-Like technology and recent biostimulatory injectable launches indicate a shift toward regenerative aesthetics and skin quality solutions, suggesting upsell potential to clinics seeking next‑generation injectables and combination therapies.

Strategic Partnerships Recent partner announcements with Obagi Cosmeceuticals signal openness to strategic collaborations; explore channel partnerships, co‑development of treatment protocols, and cross‑sell opportunities with broader professional skincare portfolios.

Sales Leadership New regional sales leadership for the UK and Ireland plus global expansions point to ramped up sales capacity; target high‑value clinics and medical groups with tailored curricula, clinical datasheets, and in‑person product demonstrations.

Innovation Pipeline Continued product introductions (calcium hydroxyapatite biostimulators, polynucleotide skin boosters) indicate a robust product roadmap; leverage early access programs, case studies, and education events to secure practitioner adoption and multi‑product sales.